Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - NetShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Short-term Investments (2016 - 2018)

Historic Short-term Investments for Sanofi (SNY) over the last 13 years, with Q4 2021 value amounting to $12.5 million.

  • Sanofi's Short-term Investments fell 9318.24% to $12.5 million in Q4 2021 from the same period last year, while for Dec 2021 it was $12.5 million, marking a year-over-year decrease of 9318.24%. This contributed to the annual value of $12.9 million for FY2021, which is 9263.54% down from last year.
  • Per Sanofi's latest filing, its Short-term Investments stood at $12.5 million for Q4 2021, which was down 9318.24% from $182.9 million recorded in Q4 2020.
  • Sanofi's Short-term Investments' 5-year high stood at $227.1 million during Q4 2018, with a 5-year trough of $12.5 million in Q4 2021.
  • Over the past 5 years, Sanofi's median Short-term Investments value was $147.0 million (recorded in 2019), while the average stood at $132.0 million.
  • Per our database at Business Quant, Sanofi's Short-term Investments surged by 17086.46% in 2017 and then plummeted by 9318.24% in 2021.
  • Sanofi's Short-term Investments (Quarter) stood at $90.7 million in 2017, then surged by 150.53% to $227.1 million in 2018, then crashed by 35.28% to $147.0 million in 2019, then increased by 24.42% to $182.9 million in 2020, then plummeted by 93.18% to $12.5 million in 2021.
  • Its last three reported values are $12.5 million in Q4 2021, $182.9 million for Q4 2020, and $147.0 million during Q4 2019.